A case report : 34 y.o male with incidental histopathological findings of Kaposi sarcoma without clinical history of human immunodeficiency virus (HIV)
DOI:
https://doi.org/10.33448/rsd-v12i10.43103Keywords:
Kaposi sarcoma; Skin lesion; Incidental histopathological findings.Abstract
Introduction: Kaposi sarcoma is a rare and challenging case especially in immunosuppressed patients that frequently doesn’t have specific manifestation. It usually caused by human herpes virus 8 virus infection and male patient with multiple lesion has high mortality rates. The aim of this study is to report 34 y.o Male with incidental histopathological findings of kaposi sarcoma without clinical history of Human Immunodeficiency Virus (HIV). Methodology: Descriptive study of the case report type, whose data were obtained from the patient's medical record. Result: This paper will report 34-year-old young adult male with clinically diagnosed with poroma and differential diagnosis of squamous cell carcinoma and pyogenic granuloma. The clinical sign was multiple skin lesion appear on his right nose and thumb in the last 6 months. The nodules are solitary with oval shape, erythema, firm borders and the nodule surface covered with brownish-yellow squama. In addition, imaging examination suspicious for soft tissue mass. The biopsy was performed, and histopathological finding exhibit a tumor mass consists of Kaposi sarcoma. Discussion: Furthermore, after pathological report revealed the diagnosis of Kaposi sarcoma then a provider-initiated HIV testing and counseling (PITC) examination is carried out and the test result showed reactive for HIV infection. So that, patient concluded to have predisposition of HIV infection with Kaposi sarcoma and treated for antiretrovirals (ARV), chemotherapy and routine clinical follow up. Conclusion : Kaposi sarcoma is a rare cancer caused by infection with the human herpesvirus 8 (HHV8). These lesions are often found in immunosuppressed patients such as HIV sufferers characterized by vascular proliferation. Through the incidental findings of Kaposi's sarcoma in patients who are not clinically suspected of having HIV, clinicopathological correlation is highly recommended. Therefore, the purpose of this writing can be a strong reference so that clinicians are more thorough in reviewing clinical patients and more detailed physical examinations.
References
Abdulameer, S.,at al. (2022). Kaposi sarcoma. In: PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/softtissuekaposi.html
Bergman, R., Guttman-Yassky, E. & Sarid, R. (2008). Kaposi sarcoma. In: Nouri K, editor. skin cancer. McGraw-Hill; 317-35
Billings, S. (2011). Tumors and Tumor like conditions of the skin. Rosai J. Rosai and Ackerman's Surgical Pathology. (10th ed.), Mosby Elsevier; 1860-1864.
Cancer.Net Editorial Board. (2023). Statistics. https://www-cancer-net.translate.goog/cancer-types/sarcoma-kaposi/statistics?
Cesarman,E,. Damania,B,. Krown, S,. Martin, J,. Bower, M, & Whitby. (2019). Kaposi sarcoma. In Journal Pubmed ncbi website. Kaposi sarcoma - PubMed (nih.gov)
Cheng, F. (2012). Virus-host cell interplay in the pathogenesis of Kaposi's sarcoma herpesvirus. (Doctorate dissertation). Finland: Helsinki Univ.”. Authors, put to italics dissertation title "Virus-host cell interplay in the pathogenesis of Kaposi's sarcoma herpesvirus.
Eleonora, R., Vincenzo, R., Maria,T., Alessio,G., Ronni,W. & Franco, B. (2013). Kaposi Sarcoma: Etiology and pathogenesis, precipitating factors, causal associations, and treatment: Facts and controversy. Journal of Clinical Dermatology 31, 413–422
Geraminejad, P., Memar, O., Aronson, I., Rady, P. I., Hengge, U. & Tyring, S. K. (2002). Kaposi sarcoma and other manifestations of human herpesvirus 8. J Am Acad Dermatol; 47: 641-55.
Grayson, W, & Pantanowitz, L. (2008). Histological variants of cutaneous Kaposi sarcoma. Diagnostic pathology; 3:31.
Grayson, W. & Landman, G., David. E., Daniela, M., Richard A., Scolyer & Rein W. (2018) Kaposi sarcoma. Editors. WHO : Classification of Skin Tumors : IARC; 341-343.
Luca, F., Dario, D,. Francesca, R. D. P., Sofia V., Roberto, M., Giovanni P., Michele D., Francesca R, Valeria C., Francesco, R., Eleonora, C., Damiano, A. & Elena, D.(2021). Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines. (2): 171.
Mancuso, R,. Biffi, R,. Valli, M,. et al. (2008). Relationship of the HHV8 subtype to the development of classic Kaposi's sarcoma. J Med Virol. 80:2153-60.
Pereira, A. S., et al. (2018). Metodologia da pesquisa cientifica. UFSM.
Regmi, A. & Speiser, J. (2021). Poroma. Skin nonmelanocytic tumor adnexal tumors. In: PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/skintumornonmelanocyticeccrineporoma.html.
Sanna P, Roselli M, Mainetti C, Gilliet F, Sessa C, Bernier J, et al. Classical (HIV negative) cutaneous Kaposi's sarcoma: a case report and a short review of the literature. Schweiz Med Wochenschr; 130: 988-92.
Sarah Crowe, K. C., Ann Robertson, G. H., & Anthony Avery & Aziz Sheikh. (2011). The case study approach. BMC Med Res Methodology, 11:100.
Wen, K. M., & Damania, B. (2010) Kaposi sarcoma-associated herpesvirus (KSHV): Molecular biology and oncogenesis. Cancer Lett; 289: 140-50.
World Health Organization. (2021). Data visualization tools for exploring the global cancer burden in 2020. In: WHO website. https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf
World Health Organization. (2021). The Global Cancer Observatory. In: WHO website https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf
Yin, R. K. (2017). Case study, [EPub]. Sage Publications.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Herman Saputra; Ni Putu Sriwidyani; Putu Erika Paskarani; Elisabeth E. Ndori
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.